Worth reading
61In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
4800
¥ millionWording
Avoiding a definitive answer
How definitive the wording is.Revised forecast
Fiscal year ended March 2024 · Second quarter (cumulative)Previous forecast published 2023年5月11日Net Sales71,500→73,000million
+2.1%
Operating profit16,000→20,800million
+30.0%
Profit attributable to owners of the parent12,400→16,000million
+29.0%
Net income per share184.1→237.56yen and sen
+29.0%
The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Reason for the revision
ウプトラビの海外売上に伴うロイヤリティ収入と機能食品事業が好調に推移し、売上収益は当初予想を15億円上回る見込み。利益は増収に加え、研究開発費が当初予想を下回り、為替差益が大きく発生する見込み。
Previous-period results売上収益71,136百万円、営業利益19,161百万円、税引前四半期利益19,398百万円、親会社の所有者に帰属する四半期利益15,222百万円、基本的1株当たり四半期利益226.01円
Consolidated / non-consolidatedConsolidated
| Item | Details |
|---|---|
| Net Sales | ¥71,500 million → ¥73,000 million（+2.1%） |
| Operating profit | ¥16,000 million → ¥20,800 million（+30.0%） |
| Profit attributable to owners of the parent | ¥12,400 million → ¥16,000 million（+29.0%） |
| Net income per share | 184.1 yen and sen → 237.56 yen and sen |
| Fiscal Period Covered | Fiscal year ended March 2024 |
| Period Covered | Second quarter (cumulative) |
| Publication date of previous forecast | 2023年5月11日 |
| Previous-period results | 売上収益71,136百万円、営業利益19,161百万円、税引前四半期利益19,398百万円、親会社の所有者に帰属する四半期利益15,222百万円、基本的1株当たり四半期利益226.01円 |
| Reason for the revision | ウプトラビの海外売上に伴うロイヤリティ収入と機能食品事業が好調に推移し、売上収益は当初予想を15億円上回る見込み。利益は増収に加え、研究開発費が当初予想を下回り、為替差益が大きく発生する見込み。 |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (3)
Ordinary incomeDetails and amount of extraordinary lossDividend forecast revision
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.ウプトラビの海外売上に伴うロイヤリティ収入と機能食品事業が好調に推移し、売上収益が当初予想を上回る見込みとなった。利益は増収に加え、研究開発費が当初予想を下回り、為替差益が大きく発生する見込みとなった。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.